⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL62881 | 1.00 | — | — | |
| SCHEMBL64140 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL1132702 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL27622305 | 0.97 | GGT1 (0.46) | — | |
| Hydrochloric Acid SCHEMBL1132934 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL14832376 | 0.97 | GGT1 (0.46) | — | |
| Hydrochloric Acid SCHEMBL1132932 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL14832377 | 0.97 | GGT1 (0.46) | — | |
| SCHEMBL11048293 | 0.97 | — | — | |
| SCHEMBL11048301 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 531 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119192296-A | Polypeptide compound, pharmaceutical composition and application | 杭州禾泰健宇生物科技有限公司 | 2024-12-27 | — | — | CN | claimed |
| US-10077438-B2 | Modifications of peptide compositions to increase stability and delivery efficiency | KAI PHARMACEUTICALS, INC. (US) | 2018-09-18 | — | — | US | claimed |
| US-20160318987-A1 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2016-11-03 | — | — | US | claimed |
| EP-3080153-A2 | PROTEASE RESISTANT PEPTIDES | Medimmune Limited (GB) | 2016-10-19 | — | — | EP | claimed |
| CN-105061275-A | Method for preparing high-purity chiral 2-smethylcysteine s and hydrochloride of high-purity chiral 2-smethylcysteine s | SYNCOZYMES SHANGHAI CO LTD | 2015-11-18 | — | — | CN | claimed |
| WO-2015086686-A2 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2015-06-18 | — | — | WO | claimed |
| US-20120040915-A1 | PEPTIDES AND NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2012-02-16 | — | — | US | claimed |
| US-8067532-B2 | Modifications of peptide compositions to increase stability and delivery efficiency | KAI PHARMACEUTICALS, INC. (US) | 2011-11-29 | — | — | US | claimed |
| WO-2010088527-A2 | PEPTIDES AND NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2010-08-05 | — | — | WO | claimed |
| EP-2109619-A2 | MODIFICATIONS OF PEPTIDE COMPOSITIONS TO INCREASE STABILITY AND DELIVERY EFFICIENCY | Kai Pharmaceuticals, Inc. (US) | 2009-10-21 | — | — | EP | claimed |
| US-20030236426-A1 | Synthesis of benzimidate from benzoic acid | GENZYME CORPORATION | 2003-12-25 | — | — | US | claimed |
| US-20030236435-A1 | Synthesis of 2-alkylcysteine via substituted thiazoline ester | GENZYME CORPORATION | 2003-12-25 | — | — | US | claimed |
| US-20030236404-A1 | Synthesis of 2-alkylcysteine via phase transfer catalysis | GENZYME CORPORATION | 2003-12-25 | — | — | US | claimed |
| US-20030229231-A1 | Synthesis of 2-alkylcysteine | GENZYME CORPORATION | 2003-12-11 | — | — | US | claimed |
| US-20030225287-A1 | Synthesis of chiral 2-alkyl amino acids | GENZYME CORPORATION | 2003-12-04 | — | — | US | claimed |
| US-20030220504-A1 | Synthesis of benzonitriles from substituted benzaldehyde | GENZYME CORPORATION | 2003-11-27 | — | — | US | claimed |
| WO-2003097582-A2 | SYNTHESIS OF BENZONITRILES AND BENZIMIDATES | GENZYME CORPORATION (US) | 2003-11-27 | — | — | WO | claimed |
| WO-2003097622-A2 | SYNTHESIS OF 2-ALKYLCYSTEINES, 2-(HYDROXYLATED PHENYL)-4-ALKYLTHIAZOLINE-4-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF | GENZYME CORPORATION (US) | 2003-11-27 | — | — | WO | claimed |
| EP-0045281-B1 | TRIAZOLINE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1985-05-08 | — | — | EP | claimed |
| US-4487780-A | SUBSTITUTED CYSTEINE COMPOUNDS | SCHEINBERG ISRAEL H | 1984-12-11 | — | — | US | claimed |